These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Metformin, the rebirth of a biguanide: mechanism of action and place in the prevention and treatment of insulin resistance.
    Author: Mehnert H.
    Journal: Exp Clin Endocrinol Diabetes; 2001; 109 Suppl 2():S259-64. PubMed ID: 11460576.
    Abstract:
    Metformin should be regarded as a first-choice therapy of type 2 diabetes, showing an especially good efficacy in obese patients with hyperinsulinaemia. Reduction of blood glucose without hyperinsulinaemia and without hypoglycaemia, favourable influence on the lipid profile and inhibition of coagulation factors lead to an antidiabetic and antiatherogenic effect. Not only are these characteristics relevant to judging the value of the drug, but also the strict observation of contraindications is needed to avoid the dangerous complication of lactic acidosis.
    [Abstract] [Full Text] [Related] [New Search]